A randomized, open-label, prospective, multicenter phase-III clinical trial of Elores in lower respiratory tract and urinary tract infections

Results obtained in the present study, together with microbiological evaluation data suggest that Elores is more effective and safe antibacterial agent for the treatment of LRTIs and UTIs infections.